<DOC>
	<DOCNO>NCT01605461</DOCNO>
	<brief_summary>Phase 1 study ass pharmacokinetics rout elimination single oral dose [ 14C ] -BI 207127 characterize metabolic profile follow single dose administration .</brief_summary>
	<brief_title>Study Evaluating Absorption , Distribution , Metabolism Excretion ( ADME ) Single Dose 14C-BI 207127 Healthy Male Volunteers</brief_title>
	<detailed_description />
	<criteria>Inclusion criterion : Body mass index =18.5 BMI = 29.9 kg/m2 Subject willing avoid sun exposure first administration trial drug end study Male subject must agree minimise risk female partner become pregnant dosing day three month completion study . Acceptable method contraception male volunteer include vasectomy less three month prior dose barrier contraception . For female partner male volunteer , acceptable method contraception include intrauterine device , tubal ligation , hormonal contraceptive least three month , diaphragm spermicide . Signed date write informed consent prior admission study accordance GCP local legislation . Exclusion criterion : Participation one radiolabelled investigational study drug trial within 12 month prior checkin . The previous radiolabelled study drug must receive 6 month prior checkin study total exposure study previous study within recommend level consider safe , per 21 CFR 361.1 ( eg . le 5,000 mrem whole body annual exposure ) Exposure significant radiation ( eg . serial xray compute tomography scan , barium meal , current employment job require radiation exposure monitoring ) within 12 month prior checkin Participation another trial investigational drug within two month prior administration trial drug trial Use drug might reasonably influence result trial , include use broad spectrum antibiotic , within 10 day prior administration investigational medication trial trial Intake drug halflife &gt; 24 hour within month prior administration trial medication , administration trial medication would occur time period few 10 halflives elapse Surgery gastrointestinal tract ( except appendectomy cholecystectomy ) Current smoker smoker last six month ; alcohol abuse ( 40 g/day ) ; history illicit drug abuse within past 2 year Blood donation ( 100 mL within four week prior first administration trial drug trial ) A marked baseline prolongation QT/QTc interval ( e.g. , repeated demonstration QTc interval &gt; 450 m ) ; history additional risk factor torsades de pointes ( TdP ) ( e.g. , heart failure , hypokalemia , family history Long QT Syndrome ) History photosensitivity recurrent rash Irregular defecation pattern ( le one bowel movement day )</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>February 2016</verification_date>
</DOC>